Sun Pharma FY26 Dividend: Key Dates for ₹5 Payout
What Sun Pharma announced
Sun Pharmaceutical Industries Ltd has announced key dates for its final dividend for the financial year 2025-26 (FY26). The company has proposed a final dividend of ₹5 per equity share. July 7, 2026 has been fixed as the record date to determine which shareholders are eligible. The payout is subject to approval by shareholders at the company’s Annual General Meeting (AGM).
Record date fixed: July 7, 2026
Sun Pharma said July 7, 2026 will be used to determine shareholder entitlement for the FY26 final dividend. Investors whose names appear in the company’s records as of the record date will be eligible for the dividend, subject to AGM approval. The record date is a key operational cutoff used by companies to finalise beneficiary lists. It also helps investors plan around dividend-related timelines.
Payment timeline: on or before August 7, 2026
The company stated the final dividend, if approved at the AGM, will be paid on or before August 7, 2026. This sets a clear outer deadline for the transfer of dividend money to eligible shareholders. The payment date is linked to shareholder approval and the completion of corporate processes after the AGM.
AGM details investors should note
Sun Pharma’s 34th AGM is scheduled for July 31, 2026. The meeting will be held at 4:00 pm through video conferencing. Shareholders will vote on various proposals, including the declaration of the ₹5 per share final dividend for FY26. The dividend becomes payable only after shareholders approve it at the AGM.
TDS and documentation: what the company said
Sun Pharma noted that the dividend distribution will be subject to tax deduction at source (TDS) at applicable rates. It also said shareholders need to submit necessary documents by the record date to ensure the correct TDS rate is applied. This is relevant for investors who may be eligible for a different TDS rate based on their documentation. The practical implication is that the record date acts as a deadline not only for eligibility but also for tax-related compliance.
Board recommendation and FY26 dividend context
Separately, the company has stated that the ₹5 final dividend for the year ended March 31, 2026 was recommended by its Board of Directors at a meeting held on May 22, 2026. The same update also mentioned an interim dividend of ₹11 per share declared on January 31, 2026. Taken together, the interim dividend of ₹11 and the proposed final dividend of ₹5 bring the total dividend payout for FY26 to ₹16 per share, subject to shareholder approval for the final dividend.
Dividend yield figures cited in the update
The update also provided yield calculations based on a closing price of ₹1,852.40. At that price, the ₹5 final dividend alone translates to a dividend yield of 0.27%. The full-year payout of ₹16 per share implies a total FY26 yield of approximately 0.86%. These figures are presented as arithmetic outcomes of the dividend amounts and the cited closing price.
Key dates and figures at a glance
Dividend history points mentioned
The material also included a small reference table of past and current dividend-related entries. It listed the May 22, 2026 entry for a ₹5 per share final dividend (described as 500%). It also showed a May 22, 2025 entry with a record date and ex-dividend date of July 7, 2025, and a final dividend value of ₹5.5 per share (described as 550%).
What investors typically track next
From here, the immediate checkpoint is the AGM on July 31, 2026, because shareholder approval is required for the final dividend to be paid. Investors also need to ensure their holdings reflect in records by the July 7, 2026 record date for eligibility. In addition, shareholders who need a specific TDS treatment should align their documentation submission with the record date deadline mentioned by the company. After the AGM, investors can track corporate filings and payment execution up to the “on or before” date of August 7, 2026.
Conclusion
Sun Pharma has laid out a clear calendar for its proposed FY26 final dividend of ₹5 per share, with July 7, 2026 as the record date and payment planned on or before August 7, 2026, subject to AGM approval. The 34th AGM is set for July 31, 2026 via video conferencing, where shareholders will vote on the dividend proposal.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q4 Earnings Tracker